Kinaxis (TSE:KXS) Price Target Raised to C$220.00
Kinaxis (TSE:KXS – Free Report) had its price objective lifted by Scotiabank from C$200.00 to C$220.00 in a report released on Wednesday morning, BayStreet.CA reports. They currently have an outperform rating on the stock. Other research analysts have also issued research reports about the stock. BMO Capital Markets lowered their price objective on shares of […]
More Stories
UBS Group Initiates Coverage on Pagaya Technologies (NASDAQ:PGY)
UBS Group initiated coverage on shares of Pagaya Technologies (NASDAQ:PGY – Free Report) in a research note published on Friday...
Ucommune International (NASDAQ:UK) vs. ExlService (NASDAQ:EXLS) Head-To-Head Contrast
Ucommune International (NASDAQ:UK – Get Free Report) and ExlService (NASDAQ:EXLS – Get Free Report) are both finance companies, but which...
Head to Head Review: SBC Medical Group (NASDAQ:SBC) vs. Teladoc Health (NYSE:TDOC)
SBC Medical Group (NASDAQ:SBC – Get Free Report) and Teladoc Health (NYSE:TDOC – Get Free Report) are both small-cap medical...
Financial Analysis: TSS (TSSI) & The Competition
Institutional and Insider Ownership 44.6% of shares of all “Management consulting services” companies are held by institutional investors. 30.5% of...
Comparing Simon Property Group (NYSE:SPG) and Farmland Partners (NYSE:FPI)
Simon Property Group (NYSE:SPG – Get Free Report) and Farmland Partners (NYSE:FPI – Get Free Report) are both finance companies,...
Brokerages Set TPG RE Finance Trust, Inc. (NYSE:TRTX) Price Target at $9.08
TPG RE Finance Trust, Inc. (NYSE:TRTX – Get Free Report) has been assigned an average rating of “Moderate Buy” from...